查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1404601

水肿临床试验市场规模、份额、趋势分析报告：按阶段、按市场参与企业、按研究设计、按类型、按地区、按细分市场、预测，2023-2030 年

Edema Clinical Trials Market Size, Share & Trends Analysis Report By Phase, By Participant, By Study Design, By Type, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 175 Pages | 商品交期: 2-10个工作天内

价格

水肿临床试验市场成长与趋势：

Grand View Research, Inc.最新报告显示，预计到2030年，全球水肿临床试验市场规模将达到12.7亿美元，2023年至2030年复合年增长率为5.7%。

推动市场成长的一些因素包括心臟衰竭、肾功能不全和肝硬化等基础疾病导致的水肿盛行率增加，以及医学研究中医疗开发支出的增加。

此外，水肿研究预计将推动市场扩张。例如，2021 年 8 月，诺华宣布 Beovu 治疗糖尿病黄斑部水肿的 III 期试验取得了令人鼓舞的结果，给药给药长达 16 週，显示出有效结果。 KITE 试验第 2 週和第 100 週的结果显示，大多数完成负荷阶段和第一个 12 週週期的患者仍保持 12 或 16 週的给药间隔，直到研究结束。

水肿临床试验市场报告亮点

  • 这是因为 II 期阶段涉及对更多患者进行更广泛的测试，以评估疗效和安全性。此类试验旨在完善给药、确定副作用并收集治疗效果的初步证据。
  • III 期细分市场预计复合核准为 5.5%。
  • 根据参与者的数据，2022 年成人细分市场占据最大的销售份额，达到 48.9%。这是因为成人部分可能有更长的病历，并且就其起源和严重程度而言是一个更加多样化的人群。
  • 根据试验设计，介入试验部分预计将在 2022 年占据最大的收益占有率，达到 48.2%，并在预测期内以 5.8% 的最快复合年增长率增长。该设计吸引了来自多个国家和地区的参与者，并且经常采用多中心方法。
  • 按类型划分，局部水肿细分市场在 2022 年占据最大收益占有率，达到 63.5%。某些族群局部水肿的频率和强度将增加其在特定地区和医疗机构的临床试验中的重要性。
  • 2022年，北美以41.4%的销售份额主导市场。因为北美由学术机构、研究设施和临床试验地点组成。它还拥有先进而强大的研究基础设施。预计亚太地区在预测期内将以 6.1% 的复合年增长率最快增长，中国和印度等国家将成为重要的药品生产和研究中心。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章市场变数、趋势和范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场趋势及展望
  • 市场动态
    • 市场驱动因素分析
    • 市场抑制因素分析
  • 营商环境分析
    • PESTLE分析
    • 波特五力分析
  • COVID-19感染疾病的影响分析

第四章阶段业务分析

  • 水肿临床试验市场：2022 年和 2030 年阶段变异分析
  • 第一阶段
    • 第一市场，2018-2030
  • 第二阶段
    • 二期市场，2018-2030
  • 第三阶段
    • 三期市场，2018-2030
  • 第四阶段
    • 第四期市场，2018-2030

第五章 参与者业务分析

  • 水肿临床试验市场：2022 年和 2030 年参与者变异分析
  • 小儿科
  • 成人
  • 老年医学

第六章 保荐人业务分析

  • 水肿临床试验市场：申办者变异分析，2022 年及 2030 年
  • 製药公司
    • 医药市场，2018-2030
  • 学术机构
    • 学术市场，2018-2030
  • 政府机关
    • 政府市场，2018-2030

第 7 章 类型业务分析

  • 水肿临床试验市场：类型变异分析，2022 年和 2030 年
  • 全身水肿
  • 局部水肿

第八章区域业务分析

  • 区域市场简介
  • 北美洲
    • 北美水肿临床试验市场，2018-2030
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲水肿临床试验市场，2018-2030
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 亚太地区水肿临床试验市场，2018-2030
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 拉丁美洲水肿临床试验市场，2018-2030
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • MEA 水肿临床试验市场，2018-2030
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第9章竞争形势

  • 公司分类
  • 策略规划
    • 获得
    • 合作
    • 宣布新平台
    • 其他的
  • 公司简介/名单
    • Otsuka Holdings
    • Hoffmann-La Roche
    • Novartis Pharmaceuticals
    • Bayer
    • Genentech, Inc
    • Biogen
    • Johnson &Johnson
    • Merck &Co., Inc.
    • Sanofi SA
    • AstraZeneca plc
    • Bristol Myers Squibb Company
    • GlaxoSmithKline plc
    • AbbVie Inc.
Product Code: GVR-4-68040-117-8

Edema Clinical Trials Market Growth & Trends:

The global edema clinical trials market size is expected to reach USD 1.27 billion by 2030, registering a compound annual growth rate (CAGR) of 5.7% from 2023 to 2030, according to a new report by Grand View Research, Inc. Several factors driving the growth of the market include the increasing prevalence of edema caused by underlying illnesses such as heart failure, kidney disorders, and liver cirrhosis, increasing expenditures on health care developments in medical research, among others.

In addition, edema research studies are anticipated to fuel the market's expansion. For instance, in August 2021, Novartis announced encouraging findings from Phase III studies of Beovu treating diabetic macular edema, showing effective outcomes at up to 16-week intervals between doses. The KITE study's results from week 100 of the second year showed that most patients who finished the loading phases and the first 12-week cycle were kept on a 12 or 16-week dosing interval until the study's end.

Edema Clinical Trials Market Report Highlights:

  • Based on phase, the phase-II segment accounted for the largest revenue share of 35.7% in 2022, as there is more extensive testing in a larger group of patients to assess both efficacy and safety in the phase-II segment. These trials aim to refine the dosage, identify adverse effects, and gather preliminary evidence of the treatment's effectiveness
  • The phase-III segment is expected to grow at a CAGR of 5.5% during the forecast period, as it is crucial for obtaining regulatory approval to provide strong evidence of a treatment's effectiveness and safety in a large, diverse patient population
  • Based on participant, the adult segment accounted for the largest revenue share of 48.9% in 2022 due to the possibility that they have a more extended history of the condition and a more diverse population regarding its origin and severity
  • Based on study design, the interventional trials segment accounted for the largest revenue share of 48.2% in 2022 and is expected to grow at the fastest CAGR of 5.8% over the forecast period. This design takes people from several countries and areas and frequently uses a multicenter technique
  • Based on type, the localized edema segment accounted for the largest revenue share of 63.5% in 2022. The frequency and intensity of localized edema in some populations would increase its significance in clinical trials for particular geographic areas or healthcare settings
  • In 2022, North America dominated the market with a revenue share of 41.4% as it consists of academic institutions, research facilities, and places for clinical trials. It also offers an advanced and robust research infrastructure. Asia Pacific is anticipated to grow at the fastest CAGR of 6.1% over the forecast period, with countries such as China and India serving as significant centers for pharmaceutical production and research

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Market Definitions
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Trends and Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Analysis
    • 3.3.2. Market Restraint Analysis
  • 3.4. Business Environment Analysis
    • 3.4.1. PESTLE Analysis
    • 3.4.2. Porter's Five Forces Analysis
  • 3.5. COVID-19 Impact Analysis

Chapter 4. Phase Business Analysis

  • 4.1. Edema Clinical Trials Market: Phase Movement Analysis, 2022 & 2030
  • 4.2. Phase I
    • 4.2.1. Phase I Market, 2018 - 2030 (USD Million)
  • 4.3. Phase II
    • 4.3.1. Phase II Market, 2018 - 2030 (USD Million)
  • 4.4. Phase III
    • 4.4.1. Phase III Market, 2018 - 2030 (USD Million)
  • 4.5. Phase IV
    • 4.5.1. Phase IV Market, 2018 - 2030 (USD Million)

Chapter 5. Participant Business Analysis

  • 5.1. Edema Clinical Trials Market: Participant Movement Analysis, 2022 & 2030
  • 5.2. Pediatrics
    • 5.2.1. Pediatric Market, 2018 - 2030 (USD Million)
  • 5.3. Adults
    • 5.3.1. Adults Market, 2018 - 2030 (USD Million)
  • 5.4. Geriatrics
    • 5.4.1. Geriatrics Market, 2018 - 2030 (USD Million)

Chapter 6. Sponsor Business Analysis

  • 6.1. Edema Clinical Trials Market: Sponsor Movement Analysis, 2022 & 2030
  • 6.2. Pharmaceutical Companies
    • 6.2.1. Pharmaceutical Companies Market, 2018 - 2030 (USD Million)
  • 6.3. Academic Institutions
    • 6.3.1. Academic Institutions Market, 2018 - 2030 (USD Million)
  • 6.4. Government Bodies
    • 6.4.1. Government Bodies Market, 2018 - 2030 (USD Million)

Chapter 7. Type Business Analysis

  • 7.1. Edema Clinical Trials Market: Type Movement Analysis, 2022 & 2030
  • 7.2. Systemic Edema
    • 7.2.1. Systemic Edema Market, 2018 - 2030 (USD Million)
  • 7.3. Localized Edema
    • 7.3.1. Localized Edema Market, 2018 - 2030 (USD Million)

Chapter 8. Regional Business Analysis

  • 8.1. Regional Market Snapshot
  • 8.2. North America
    • 8.2.1. North America Edema Clinical Trials Market, 2018 - 2030 (USD Million)
    • 8.2.2. U.S.
      • 8.2.2.1. U.S. Edema Clinical Trials Market, 2018 - 2030 (USD Million)
      • 8.2.2.2. Key Country Dynamics
      • 8.2.2.3. Regulatory Framework
      • 8.2.2.4. Competitive Scenario
    • 8.2.3. Canada
      • 8.2.3.1. Canada Edema Clinical Trials Market, 2018 - 2030 (USD Million)
      • 8.2.3.2. Key Country Dynamics
      • 8.2.3.3. Regulatory Framework
      • 8.2.3.4. Competitive Scenario
  • 8.3. Europe
    • 8.3.1. Europe Edema Clinical Trials Market, 2018 - 2030 (USD Million)
    • 8.3.2. Germany
      • 8.3.2.1. Germany Edema Clinical Trials Market, 2018 - 2030 (USD Million)
      • 8.3.2.2. Key Country Dynamics
      • 8.3.2.3. Regulatory Framework
      • 8.3.2.4. Competitive Scenario
    • 8.3.3. UK
      • 8.3.3.1. UK Edema Clinical Trials Market, 2018 - 2030 (USD Million)
      • 8.3.3.2. Key Country Dynamics
      • 8.3.3.3. Regulatory Framework
      • 8.3.3.4. Competitive Scenario
    • 8.3.4. France
      • 8.3.4.1. France Edema Clinical Trials Market, 2018 - 2030 (USD Million)
      • 8.3.4.2. Key Country Dynamics
      • 8.3.4.3. Regulatory Framework
      • 8.3.4.4. Competitive Scenario
    • 8.3.5. Italy
      • 8.3.5.1. Italy Edema Clinical Trials Market, 2018 - 2030 (USD Million)
      • 8.3.5.2. Key Country Dynamics
      • 8.3.5.3. Regulatory Framework
      • 8.3.5.4. Competitive Scenario
    • 8.3.6. Spain
      • 8.3.6.1. Spain Edema Clinical Trials Market, 2018 - 2030 (USD Million)
      • 8.3.6.2. Key Country Dynamics
      • 8.3.6.3. Regulatory Framework
      • 8.3.6.4. Competitive Scenario
    • 8.3.7. Denmark
      • 8.3.7.1. Denmark Edema Clinical Trials Market, 2018 - 2030 (USD Million)
      • 8.3.7.2. Key Country Dynamics
      • 8.3.7.3. Regulatory Framework
      • 8.3.7.4. Competitive Scenario
    • 8.3.8. Sweden
      • 8.3.8.1. Sweden Edema Clinical Trials Market, 2018 - 2030 (USD Million)
      • 8.3.8.2. Key Country Dynamics
      • 8.3.8.3. Regulatory Framework
      • 8.3.8.4. Competitive Scenario
    • 8.3.9. Norway
      • 8.3.9.1. Norway Edema Clinical Trials Market, 2018 - 2030 (USD Million)
      • 8.3.9.2. Key Country Dynamics
      • 8.3.9.3. Regulatory Framework
      • 8.3.9.4. Competitive Scenario
  • 8.4. Asia Pacific
    • 8.4.1. Asia Pacific Edema Clinical Trials Market, 2018 - 2030 (USD Million)
    • 8.4.2. Japan
      • 8.4.2.1. Japan Edema Clinical Trials Market, 2018 - 2030 (USD Million)
      • 8.4.2.2. Key Country Dynamics
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. Competitive Scenario
    • 8.4.3. China
      • 8.4.3.1. China Edema Clinical Trials Market, 2018 - 2030 (USD Million)
      • 8.4.3.2. Key Country Dynamics
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. Competitive Scenario
    • 8.4.4. India
      • 8.4.4.1. India Edema Clinical Trials Market, 2018 - 2030 (USD Million)
      • 8.4.4.2. Key Country Dynamics
      • 8.4.4.3. Regulatory Framework
      • 8.4.4.4. Competitive Scenario
    • 8.4.5. South Korea
      • 8.4.5.1. South Korea Edema Clinical Trials Market, 2018 - 2030 (USD Million)
      • 8.4.5.2. Key Country Dynamics
      • 8.4.5.3. Regulatory Framework
      • 8.4.5.4. Competitive Scenario
    • 8.4.6. Australia
      • 8.4.6.1. Australia Edema Clinical Trials Market, 2018 - 2030 (USD Million)
      • 8.4.6.2. Key Country Dynamics
      • 8.4.6.3. Regulatory Framework
      • 8.4.6.4. Competitive Scenario
    • 8.4.7. Thailand
      • 8.4.7.1. Thailand Edema Clinical Trials Market, 2018 - 2030 (USD Million)
      • 8.4.7.2. Key Country Dynamics
      • 8.4.7.3. Regulatory Framework
      • 8.4.7.4. Competitive Scenario
  • 8.5. Latin America
    • 8.5.1. Latin America Edema Clinical Trials Market, 2018 - 2030 (USD Million)
    • 8.5.2. Brazil
      • 8.5.2.1. Brazil Edema Clinical Trials Market, 2018 - 2030 (USD Million)
      • 8.5.2.2. Key Country Dynamics
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. Competitive Scenario
    • 8.5.3. Mexico
      • 8.5.3.1. Mexico Edema Clinical Trials Market, 2018 - 2030 (USD Million)
      • 8.5.3.2. Key Country Dynamics
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. Competitive Scenario
    • 8.5.4. Argentina
      • 8.5.4.1. Argentina Edema Clinical Trials Market, 2018 - 2030 (USD Million)
      • 8.5.4.2. Key Country Dynamics
      • 8.5.4.3. Regulatory Framework
      • 8.5.4.4. Competitive Scenario
  • 8.6. MEA
    • 8.6.1. MEA Edema Clinical Trials Market, 2018 - 2030 (USD Million)
    • 8.6.2. South Africa
      • 8.6.2.1. South Africa Edema Clinical Trials Market, 2018 - 2030 (USD Million)
      • 8.6.2.2. Key Country Dynamics
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. Competitive Scenario
    • 8.6.3. Saudi Arabia
      • 8.6.3.1. Saudi Arabia Edema Clinical Trials Market, 2018 - 2030 (USD Million)
      • 8.6.3.2. Key Country Dynamics
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. Competitive Scenario
    • 8.6.4. UAE
      • 8.6.4.1. UAE Edema Clinical Trials Market, 2018 - 2030 (USD Million)
      • 8.6.4.2. Key Country Dynamics
      • 8.6.4.3. Regulatory Framework
      • 8.6.4.4. Competitive Scenario
    • 8.6.5. Kuwait
      • 8.6.5.1. Kuwait Edema Clinical Trials Market, 2018 - 2030 (USD Million)
      • 8.6.5.2. Key Country Dynamics
      • 8.6.5.3. Regulatory Framework
      • 8.6.5.4. Competitive Scenario

Chapter 9. Competitive Landscape

  • 9.1. Company Categorization
  • 9.2. Strategy Mapping
    • 9.2.1. Acquisition
    • 9.2.2. Collaborations
    • 9.2.3. New Platform Launches
    • 9.2.4. Others
  • 9.3. Company Profiles/Listing
    • 9.3.1. Otsuka Holdings
      • 9.3.1.1. Company Overview
      • 9.3.1.2. Financial Performance
      • 9.3.1.3. Platform Benchmarking
      • 9.3.1.4. Strategic Initiatives
    • 9.3.2. Hoffmann-La Roche
      • 9.3.2.1. Company Overview
      • 9.3.2.2. Financial Performance
      • 9.3.2.3. Platform Benchmarking
      • 9.3.2.4. Strategic Initiatives
    • 9.3.3. Novartis Pharmaceuticals
      • 9.3.3.1. Company Overview
      • 9.3.3.2. Financial Performance
      • 9.3.3.3. Platform Benchmarking
      • 9.3.3.4. Strategic Initiatives
    • 9.3.4. Bayer
      • 9.3.4.1. Company Overview
      • 9.3.4.2. Financial Performance
      • 9.3.4.3. Platform Benchmarking
      • 9.3.4.4. Strategic Initiatives
    • 9.3.5. Genentech, Inc
      • 9.3.5.1. Company Overview
      • 9.3.5.2. Financial Performance
      • 9.3.5.3. Platform Benchmarking
      • 9.3.5.4. Strategic Initiatives
    • 9.3.6. Biogen
      • 9.3.6.1. Company Overview
      • 9.3.6.2. Financial Performance
      • 9.3.6.3. Platform Benchmarking
      • 9.3.6.4. Strategic Initiatives
    • 9.3.7. Johnson & Johnson
      • 9.3.7.1. Company Overview
      • 9.3.7.2. Financial Performance
      • 9.3.7.3. Platform Benchmarking
      • 9.3.7.4. Strategic Initiatives
    • 9.3.8. Merck & Co., Inc.
      • 9.3.8.1. Company Overview
      • 9.3.8.2. Financial Performance
      • 9.3.8.3. Platform Benchmarking
      • 9.3.8.4. Strategic Initiatives
    • 9.3.9. Sanofi S.A.
      • 9.3.9.1. Company Overview
      • 9.3.9.2. Financial Performance
      • 9.3.9.3. Platform Benchmarking
      • 9.3.9.4. Strategic Initiatives
    • 9.3.10. AstraZeneca plc
      • 9.3.10.1. Company Overview
      • 9.3.10.2. Financial Performance
      • 9.3.10.3. Platform Benchmarking
      • 9.3.10.4. Strategic Initiatives
    • 9.3.11. Bristol Myers Squibb Company
      • 9.3.11.1. Company Overview
      • 9.3.11.2. Financial Performance
      • 9.3.11.3. Platform Benchmarking
      • 9.3.11.4. Strategic Initiatives
    • 9.3.12. GlaxoSmithKline plc
      • 9.3.12.1. Company Overview
      • 9.3.12.2. Financial Performance
      • 9.3.12.3. Platform Benchmarking
      • 9.3.12.4. Strategic Initiatives
    • 9.3.13. AbbVie Inc.
      • 9.3.13.1. Company Overview
      • 9.3.13.2. Financial Performance
      • 9.3.13.3. Platform Benchmarking
      • 9.3.13.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of Abbreviations
  • Table 3 Global Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
  • Table 4 Global Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
  • Table 5 Global Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
  • Table 6 Global Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
  • Table 7 Global Edema Clinical Trial Market by Region, 2018 - 2030 (USD Million)
  • Table 8 North America Edema Clinical Trial Market by Country, 2018 - 2030 (USD Million)
  • Table 9 North America Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
  • Table 10 North America Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
  • Table 11 North America Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
  • Table 12 North America Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
  • Table 13 U.S. Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
  • Table 14 U.S. Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
  • Table 15 U.S. Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
  • Table 16 U.S. Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
  • Table 17 Canada Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
  • Table 18 Canada Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
  • Table 19 Canada Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
  • Table 20 Canada Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
  • Table 21 Europe Edema Clinical Trial Market by Country, 2018 - 2030 (USD Million)
  • Table 22 Europe Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
  • Table 23 Europe Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
  • Table 24 Europe Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
  • Table 25 Europe Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
  • Table 26 Germany Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
  • Table 27 Germany Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
  • Table 28 Germany Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
  • Table 29 Germany Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
  • Table 30 UK Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
  • Table 31 UK Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
  • Table 32 UK Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
  • Table 33 UK Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
  • Table 34 France Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
  • Table 35 France Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
  • Table 36 France Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
  • Table 37 France Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
  • Table 38 Italy Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
  • Table 39 Italy Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
  • Table 40 Italy Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
  • Table 41 Italy Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
  • Table 42 Spain Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
  • Table 43 Spain Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
  • Table 44 Spain Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
  • Table 45 Spain Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
  • Table 46 Denmark Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
  • Table 47 Denmark Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
  • Table 48 Denmark Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
  • Table 49 Denmark Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
  • Table 50 Sweden Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
  • Table 51 Sweden Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
  • Table 52 Sweden Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
  • Table 53 Sweden Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
  • Table 54 Norway Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
  • Table 55 Norway Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
  • Table 56 Norway Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
  • Table 57 Norway Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
  • Table 58 Asia Pacific Edema Clinical Trial Market by Country, 2018 - 2030 (USD Million)
  • Table 59 Asia Pacific Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
  • Table 60 Asia Pacific Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
  • Table 61 Asia Pacific Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
  • Table 62 Asia Pacific Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
  • Table 63 China Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
  • Table 64 China Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
  • Table 65 China Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
  • Table 66 China Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
  • Table 67 Japan Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
  • Table 68 Japan Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
  • Table 69 Japan Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
  • Table 70 Japan Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
  • Table 71 India Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
  • Table 72 India Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
  • Table 73 India Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
  • Table 74 India Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
  • Table 75 South Korea Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
  • Table 76 South Korea Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
  • Table 77 South Korea Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
  • Table 78 South Korea Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
  • Table 79 Australia Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
  • Table 80 Australia Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
  • Table 81 Australia Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
  • Table 82 Australia Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
  • Table 83 Thailand Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
  • Table 84 Thailand Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
  • Table 85 Thailand Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
  • Table 86 Thailand Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
  • Table 87 Latin America Edema Clinical Trial Market by Country, 2018 - 2030 (USD Million)
  • Table 88 Latin America Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
  • Table 89 Latin America Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
  • Table 90 Latin America Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
  • Table 91 Latin America Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
  • Table 92 Brazil Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
  • Table 93 Brazil Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
  • Table 94 Brazil Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
  • Table 95 Brazil Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
  • Table 96 Mexico Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
  • Table 97 Mexico Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
  • Table 98 Mexico Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
  • Table 99 Mexico Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
  • Table 100 Argentina Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
  • Table 101 Argentina Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
  • Table 102 Argentina Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
  • Table 103 Argentina Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
  • Table 104 Middle East & Africa Edema Clinical Trial Market by Country, 2018 - 2030 (USD Million)
  • Table 105 Middle East & Africa Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
  • Table 106 Middle East & Africa Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
  • Table 107 Middle East & Africa Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
  • Table 108 Middle East & Africa Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
  • Table 109 South Africa Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
  • Table 110 South Africa Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
  • Table 111 South Africa Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
  • Table 112 South Africa Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
  • Table 113 Saudi Arabia Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
  • Table 114 Saudi Arabia Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
  • Table 115 Saudi Arabia Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
  • Table 116 Saudi Arabia Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
  • Table 117 UAE Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
  • Table 118 UAE Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
  • Table 119 UAE Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
  • Table 120 UAE Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
  • Table 121 Kuwait Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
  • Table 122 Kuwait Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
  • Table 123 Kuwait Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
  • Table 124 Kuwait Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Edema Clinical Trial Market: Market Segmentation
  • Fig. 7 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 8 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 9 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 10 Penetration & Growth Prospect Mapping
  • Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 12 Porter's Five Forces Analysis
  • Fig. 13 Market Penetration Vs Growth Prospect Mapping, 2021
  • Fig. 14 Regional Marketplace: Key Takeaways
  • Fig. 15 Global Edema Clinical Trial Market for Phase I, 2018 - 2030 (USD Million)
  • Fig. 16 Global Edema Clinical Trial Market for Phase II, 2018 - 2030 (USD Million)
  • Fig. 17 Global Edema Clinical Trial Market for Phase III, 2018 - 2030 (USD Million)
  • Fig. 18 Global Edema Clinical Trial Market for Phase IV, 2018 - 2030 (USD Million)
  • Fig. 19 Global Edema Clinical Trial Market for Pediatrics , 2018 - 2030 (USD Million)
  • Fig. 20 Global Edema Clinical Trial Market for Adults, 2018 - 2030 (USD Million)
  • Fig. 21 Global Edema Clinical Trial Market for Geriatrics, 2018 - 2030 (USD Million)
  • Fig. 22 Global Edema Clinical Trial Market for Pharmaceutical Companies, 2018 - 2030 (USD Million)
  • Fig. 23 Global Edema Clinical Trial Market for Academic Institutions, 2018 - 2030 (USD Million)
  • Fig. 24 Global Edema Clinical Trial Market for Government Bodies, 2018 - 2030 (USD Million)
  • Fig. 25 Global Edema Clinical Trial Market for Systemic Edema, 2018 - 2030 (USD Million)
  • Fig. 26 Global Edema Clinical Trial Market for Localized Edema, 2018 - 2030 (USD Million)
  • Fig. 27 Regional Outlook, 2022 & 2030
  • Fig. 28 North America Edema Clinical Trial Market 2018 - 2030 (USD Million)
  • Fig. 29 U.S. Edema Clinical Trial Market 2018 - 2030 (USD Million)
  • Fig. 30 Canada Edema Clinical Trial Market 2018 - 2030 (USD Million)
  • Fig. 31 Europe Edema Clinical Trial Market 2018 - 2030 (USD Million)
  • Fig. 32 Germany Edema Clinical Trial Market 2018 - 2030 (USD Million)
  • Fig. 33 UK Edema Clinical Trial Market 2018 - 2030 (USD Million)
  • Fig. 34 France Edema Clinical Trial Market 2018 - 2030 (USD Million)
  • Fig. 35 Italy Edema Clinical Trial Market 2018 - 2030 (USD Million)
  • Fig. 36 Spain Edema Clinical Trial Market 2018 - 2030 (USD Million)
  • Fig. 37 Denmark Edema Clinical Trial Market 2018 - 2030 (USD Million)
  • Fig. 38 Sweden Edema Clinical Trial Market 2018 - 2030 (USD Million)
  • Fig. 39 Norway Edema Clinical Trial Market 2018 - 2030 (USD Million)
  • Fig. 40 Asia Pacific Edema Clinical Trial Market 2018 - 2030 (USD Million)
  • Fig. 41 Japan Edema Clinical Trial Market 2018 - 2030 (USD Million)
  • Fig. 42 China Edema Clinical Trial Market 2018 - 2030 (USD Million)
  • Fig. 43 India Edema Clinical Trial Market 2018 - 2030 (USD Million)
  • Fig. 44 Australia Edema Clinical Trial Market 2018 - 2030 (USD Million)
  • Fig. 45 South Korea Edema Clinical Trial Market 2018 - 2030 (USD Million)
  • Fig. 46 Thailand Edema Clinical Trial Market 2018 - 2030 (USD Million)
  • Fig. 47 Latin America Edema Clinical Trial Market 2018 - 2030 (USD Million)
  • Fig. 48 Brazil Edema Clinical Trial Market 2018 - 2030 (USD Million)
  • Fig. 49 Mexico Edema Clinical Trial Market 2018 - 2030 (USD Million)
  • Fig. 50 Argentina Edema Clinical Trial Market 2018 - 2030 (USD Million)
  • Fig. 51 Middle East and Africa Edema Clinical Trial Market 2018 - 2030 (USD Million)
  • Fig. 52 South Africa Edema Clinical Trial Market 2018 - 2030 (USD Million)
  • Fig. 53 Saudi Arabia Edema Clinical Trial Market 2018 - 2030 (USD Million)
  • Fig. 54 UAE Edema Clinical Trial Market 2018 - 2030 (USD Million)
  • Fig. 55 Kuwait Edema Clinical Trial Market 2018 - 2030 (USD Million)